Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties

Details for Australian Patent Application No. 2008350907 (hide)

Owner Viamet Pharmaceuticals, Inc.

Inventors Schotzinger, Robert J.; Hoekstra, William J.

Agent Fisher Adams Kelly

Pub. Number AU-A-2008350907

PCT Pub. Number WO2009/105140

Priority 61/007,206 11.12.07 US

Filing date 3 December 2008

Wipo publication date 27 August 2009

International Classifications

A61K 31/10 (2006.01)

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/37 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/382 (2006.01) - having six-membered rings, e.g. thioxanthenes

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/404 (2006.01)

A61K 31/431 (2006.01)

A61K 31/437 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/5513 (2006.01)

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/105140 Priority application(s): WO2009/105140

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008350910-ECP brake with dual mode empty load

2008350903-Compositions for enhanced uptake of viral vectors in the myocardium